Hidetaka Nomura Selected Research

Adenomyoma

3/2018	Maintenance hormonal therapy after treatment with medroxyprogesterone acetate for patients with atypical polypoid adenomyoma.
1/2016	Long-term outcomes of fertility-sparing treatment of atypical polypoid adenomyoma with medroxyprogesterone acetate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hidetaka Nomura Research Topics

Disease

16	Neoplasms (Cancer) 03/2024 - 07/2014
11	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2024 - 03/2016
10	Ovarian Neoplasms (Ovarian Cancer) 03/2024 - 05/2012
8	Carcinoma (Carcinomatosis) 10/2023 - 05/2012
6	Endometrial Neoplasms (Endometrial Cancer) 05/2022 - 01/2015
4	Sarcoma (Soft Tissue Sarcoma) 10/2022 - 01/2019
4	Neoplasm Metastasis (Metastasis) 07/2020 - 01/2012
3	Lymphatic Metastasis 09/2022 - 09/2017
2	Oral Leukoplakia 04/2022 - 02/2018
2	Uterine Neoplasms (Uterine Cancer) 01/2022 - 11/2021
2	Endometrial Hyperplasia 01/2022 - 02/2017
2	Margins of Excision 05/2021 - 01/2019
2	Anastomotic Leak 03/2021 - 01/2018
2	Adenomyoma 03/2018 - 01/2016
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2018 - 02/2015
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Myoma 10/2022
1	Colorectal Neoplasms (Colorectal Cancer) 05/2022
1	Tongue Neoplasms (Tongue Neoplasm) 04/2022
1	Internal Hernia 01/2021
1	Disease Progression 09/2020
1	Carcinogenesis 05/2020
1	Adenoid Cystic Carcinoma (Cylindroma) 05/2020
1	Wounds and Injuries (Trauma) 11/2019
1	Pneumoperitoneum 11/2019
1	Menstruation Disturbances 03/2018
1	Endometrioid Carcinoma 03/2018
1	Adenocarcinoma 09/2017
1	Ovarian Epithelial Carcinoma 10/2015
1	Clear Cell Adenocarcinoma 02/2015
1	Vaginal Diseases 02/2015

Drug/Important Bio-Agent (IBA)

3	Hormones (Hormone)IBA 07/2020 - 03/2018
2	AntigensIBA 03/2024 - 09/2017
2	Proteins (Proteins, Gene)FDA Link 05/2022 - 09/2020
2	liposomal doxorubicin (Doxil)FDA Link 04/2022 - 02/2018
2	1-dodecylpyridoxal (PLD)IBA 04/2022 - 02/2018
2	Progestins (Progestagens)IBA 01/2022 - 03/2018
2	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 03/2018 - 01/2016
2	PlatinumIBA 09/2017 - 01/2015
1	Docetaxel (Taxotere)FDA Link 10/2023
1	Carboplatin (JM8)FDA LinkGeneric 10/2023
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 09/2022
1	RNA (Ribonucleic Acid)IBA 01/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021
1	Estrogen ReceptorsIBA 09/2020
1	Progesterone Receptors (Progesterone Receptor)IBA 09/2020
1	Sucrose (Saccharose)IBA 09/2020
1	Bevacizumab (Avastin)FDA Link 09/2020
1	Progesterone FDA LinkGeneric 07/2020
1	ElementsIBA 02/2017
1	Diethylstilbestrol (Stilbestrol)FDA Link 02/2015
1	sparfosic acid (PALA)IBA 01/2015

Therapy/Procedure

13	Hysterectomy 01/2024 - 02/2017
8	Lymph Node Excision (Lymph Node Dissection) 09/2022 - 01/2015
8	Drug Therapy (Chemotherapy) 01/2022 - 01/2012
7	Salpingo-oophorectomy 03/2024 - 02/2017
7	Therapeutics 10/2023 - 05/2016
5	Pelvic Exenteration 12/2023 - 01/2018
4	Radiotherapy 01/2021 - 02/2015
3	Adjuvant Chemotherapy 10/2023 - 05/2012
3	Chemoradiotherapy 09/2017 - 02/2015
2	Operative Surgical Procedures 01/2023 - 05/2019
2	Morcellation 10/2022 - 11/2019
2	Cytoreduction Surgical Procedures 03/2021 - 09/2017
2	Aftercare (After-Treatment) 03/2018 - 02/2015
2	Neoadjuvant Therapy 02/2015 - 07/2014
1	Overlapping Surgery 01/2023
1	Minimally Invasive Surgical Procedures 01/2023
1	Uterine Myomectomy 10/2022
1	Conservative Treatment 01/2022
1	Trachelectomy 09/2021
1	Length of Stay 03/2021
1	Cesarean Section (Caesarean Section) 07/2020
1	Brachytherapy 07/2020
1	Precision Medicine 05/2020
1	Oral Diagnosis (Oral Examination) 02/2018
1	Ileostomy 01/2018
1	Nephroureterectomy 09/2017